 |
|
A 55-Year-Old Man With Attention-Deficit/Hyperactivity Disorder, 1 Year Later
Richard A. Parker, MD;
Erin E. Hartman, MS
From the Division of General Medicine, Beth Israel Deaconess Medical Center, 330 Brookline Ave, LY318, Boston, MA 02215.
JAMA. 1999;281:1945.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In March 1998, at Psychiatry Grand Rounds, Joseph Biederman, MD, discussed the epidemiology, diagnosis, and treatment of attention-deficit/hyperactivity disorder (ADHD).1 Mr L, a 55-year-old man, had recently started taking methylphenidate hydrochloride, 10 mg 3 times per day. He reported almost immediate improvement in his ability to concentrate and reflected on substantial advances in relationships both at home and at work. His only complaint was occasionally feeling "a little speedy." Dr Biederman suggested that Mr L would do well if he continued working with his physicians and taking methylphenidate or another appropriate medication.
MR L, THE PATIENT
I joined a group for patients with ADHD for 12 weeks, found it very useful, and remained conscientious about taking Ritalin [methylphenidate hydrochloride], 10 mg 3 to 4 times per day. I took Prozac [fluoxetine hydrochloride] for 5 months but don't seem to need it now. I reflected on time . . . [Full Text of this Article]
|
